Financial results - HELIANTHUS PHARM SRL

Financial Summary - Helianthus Pharm Srl
Unique identification code: 16359958
Registration number: J2004000819222
Nace: 4773
Sales - Ron
548.874
Net Profit - Ron
-32.720
Employees
9
Open Account
Company Helianthus Pharm Srl with Fiscal Code 16359958 recorded a turnover of 2024 of 548.874, with a net profit of -32.720 and having an average number of employees of 9. The company operates in the field of Comerţ cu amănuntul al produselor farmaceutice having the NACE code 4773.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Helianthus Pharm Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 598.587 536.582 574.621 613.781 730.954 811.883 685.631 613.860 576.057 548.874
Total Income - EUR 621.418 565.048 592.808 656.415 751.783 833.112 732.413 633.434 589.407 559.382
Total Expenses - EUR 506.134 522.023 569.441 645.420 734.706 769.875 640.640 609.398 712.219 592.102
Gross Profit/Loss - EUR 115.283 43.025 23.367 10.995 17.077 63.238 91.773 24.036 -122.812 -32.720
Net Profit/Loss - EUR 96.809 35.416 18.269 4.445 9.559 57.058 84.595 17.828 -126.651 -32.720
Employees 15 16 15 15 13 13 11 9 9 9
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales decreased by -4.2%, from 576.057 euro in the year 2023, to 548.874 euro in 2024.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Helianthus Pharm Srl

Rating financiar

Financial Rating -
HELIANTHUS PHARM SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Helianthus Pharm Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Helianthus Pharm Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Helianthus Pharm Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Helianthus Pharm Srl - CUI 16359958

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 16.712 14.628 15.218 30.019 31.023 25.344 37.411 57.550 41.431 15.928
Current Assets 352.970 172.751 194.915 182.564 222.824 297.552 266.186 215.996 120.016 90.512
Inventories 36.023 60.167 77.478 61.261 13.882 12.531 39.247 76.731 36.450 45.406
Receivables 64.660 13.900 86.536 116.589 95.313 183.556 89.027 136.099 70.218 43.967
Cash 252.286 98.684 30.901 4.713 113.630 101.465 137.911 3.167 13.348 1.139
Shareholders Funds 199.187 35.597 18.446 22.552 31.675 57.225 76.640 17.992 -126.487 -158.500
Social Capital 45 45 44 43 42 41 40 41 40 40
Debts 170.494 151.782 191.687 190.031 222.173 265.836 227.119 255.554 288.156 264.947
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4773 - 4773"
CAEN Financial Year 4773
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 90.512 euro in 2024 which includes Inventories of 45.406 euro, Receivables of 43.967 euro and cash availability of 1.139 euro.
The company's Equity was valued at -158.500 euro, while total Liabilities amounted to 264.947 euro. Equity decreased by -32.720 euro, from -126.487 euro in 2023, to -158.500 in 2024.

Risk Reports Prices

Reviews - Helianthus Pharm Srl

Comments - Helianthus Pharm Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.